- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06092840
Effect of Transform Burn on Weight Loss (Transform)
October 16, 2023 updated by: 4Life Research, LLC
Effect of a Thermogenic Composition on Healthy Adult Women and Men in a 12-week Weight Management Study
This study was undertaken to explore the effects of a Thermogenic Composition (TC) composed of dihydrocapsiate, red pepper (Capsicum annuum) fruit extract, citrus (Citrus spp) peel extract, coleus (Coleus forskholi) root extract, and african mango (Irvingia gabonensis) seed extract to support body composition, weight management, and improve parameters related to energy, hunger, and satiety on healthy adult women and men over a 12-week interval.
Study Overview
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Utah
-
Sandy, Utah, United States, 84070
- 4Life Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Individuals could participate who were at least 18 years old and not smokers.
- Not currently taking a dietary supplement or prescription for weight loss.
- Exercising volunteers were asked to maintain their regimen consistently throughout the course of the 12-week study and caffeine drinking volunteers maintained their caffeine intake consistently throughout the course of the 12-week study.
Exclusion Criteria:
- Participants were not allowed to participate if they were pregnant or planning to become pregnant in the following 12 weeks, or lactating.
- Individuals were not allowed to participate if they were taking any stimulant medications.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Transform Burn
Participants were supplied with one bottle of study product (Transform Burn) for each visit, labeled with their participant number.
They were required to take the product consisting of 4 capsules per day, taken on an empty stomach at least 30 minutes prior to eating each morning, 5 days on Monday through Friday.
Product was taken at the beginning of each visit, except for Week 0 visit for a total of 12 weeks and bottles were returned at each visit.
|
Study product Transform Burn contains dihydrocapsiate, red pepper (Capsicum annuum) fruit extract, citrus (Citrus spp) peel extract, coleus (Coleus forskholi) root extract, and african mango (Irvingia gabonensis) seed extract.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satiety Score
Time Frame: 12 weeks
|
Results obtained from a validated ten-point scale Visual Analog Scale (VAS).
On a scale 1 - 10, with the lowest being 1 and the highest being 10.
|
12 weeks
|
Resting Metabolic Rate
Time Frame: 12 weeks
|
Resting metabolic rate (RMR) was measured by MedGem by MicroLife Medical Home Solutions, participants were in quiet, thermo-neutral environment, in a seated position, resting in a comfortable or reclined position for 5-15 minutes prior to measurement, without caffeine, food or exercise for at least four hours, with mouth-piece and nose-clip on, making sure of a good seal around the mouth and nose, holding MedGem device with arm support (e. g., pillow or opposite hand).
|
12 weeks
|
Blood Pressures
Time Frame: 12 weeks
|
Both systolic and diastolic pressures were measured using the Omron Intellisense digital blood pressure monitor, Model HEM-739.
Participants were measured in a seated position, left arm rested on the chair (or table) so that the cuff was at the same level as the heart, returned the palm upward, remained still and not talk.
|
12 weeks
|
Heart Rates
Time Frame: 12 weeks
|
Heart rates were measured using the Omron Intellisense digital blood pressure monitor, Model HEM-739.
Participants were measured in a seated position, left arm rested on the chair (or table) so that the cuff was at the same level as the heart, returned the palm upward, remained still and not talk.
|
12 weeks
|
Glucose Levels
Time Frame: 12 weeks
|
Glucose levels were measured by CardioChek Plus.
Participants were measured in a seated position with the index finger cleaned with an alcohol wipe dry until dried, a sterile lancet was used to puncture the skin on the side of the fingertip, around 100 microliter of blood was collected.
With the glucose test strip already inserted into the device, 35-40 microliter of blood was applied to the test strip window and results appeared in approximately two minutes after.
|
12 weeks
|
Cholesterol Levels
Time Frame: 12 weeks
|
Cholesterol levels were measured by CardioChek Plus.
Participants were measured in a seated position with the index finger cleaned with an alcohol wipe dry until dried, a sterile lancet was used to puncture the skin on the side of the fingertip, around 100 microliter of blood was collected.
|
12 weeks
|
Body Fat
Time Frame: 12 weeks
|
Body fat were measured by a pre-calibrated Tanita BC-418 Body Composition Analyzer, participants were measured in a standing position with shoes and socks removed, without exercise for at least four hours prior to the measurement, on an empty bladder, with both arms held straight down, not touching sides, inner thighs not touching, and feet cleaned.
|
12 weeks
|
Body Weight
Time Frame: 12 weeks
|
Body weights were measured by a pre-calibrated Tanita BC-418 Body Composition Analyzer, participants were measured in a standing position with shoes and socks removed, without exercise for at least four hours prior to the measurement, on an empty bladder, with both arms held straight down, not touching sides, inner thighs not touching, and feet cleaned.
|
12 weeks
|
Waist and Hip Ratio (WHR)
Time Frame: 12 weeks
|
Waist and hip circumference measurements were measured according to the US National Health and Nutrition Examination Survey III protocol.
Participants were measured in a standing position, waist measurement was made at the high point of the iliac crest, hip measurement was made at the maximum extension of the buttocks, tape was parallel to the floor and snug, but not compressing skin.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: David Vollmer, PhD, 4LIFE
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 23, 2016
Primary Completion (Actual)
June 22, 2016
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
October 11, 2023
First Submitted That Met QC Criteria
October 16, 2023
First Posted (Actual)
October 23, 2023
Study Record Updates
Last Update Posted (Actual)
October 23, 2023
Last Update Submitted That Met QC Criteria
October 16, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RSC-009-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Medical University of ViennaCompleted
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Suspended
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Transform Burn
-
Sadick Research GroupWithdrawn
-
Simon Fraser UniversityFraser HealthCompleted
-
International Care Ministries, PhilippinesActive, not recruitingHealth Behavior | Economic Problems | Values, SocialUganda
-
Stryker NeurovascularCompleted
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...TerminatedBurns | Wound HealingUnited States
-
The University of QueenslandCompleted
-
Asan Medical CenterHangang Sacred Heart HospitalCompleted
-
Universiteit AntwerpenResearch Foundation FlandersCompleted
-
Instituto Venezolano de Investigaciones CientificasHospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, Yaracuy; Unidad... and other collaboratorsEnrolling by invitation